Company Filing History:
Years Active: 2021-2022
Title: Innovations by Jangjoon Park
Introduction
Jangjoon Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in pain treatment and therapeutic delivery methods. With a total of two patents to his name, Park is recognized for his innovative approaches to addressing complex medical challenges.
Latest Patents
Jangjoon Park's latest patents include a composition for treating pain and a method for the delivery of biological molecules to nervous tissue. The first patent relates to a composition designed to alleviate or treat pain, which comprises glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine. This innovative composition aims to provide effective pain relief. The second patent focuses on a method for delivering therapeutic agents to nervous tissue, particularly those protected by the brain-blood barrier or meninges. This method ensures high efficiency in delivering therapeutic agents while minimizing side effects, such as nervous damage, compared to traditional administration methods.
Career Highlights
Jangjoon Park is currently associated with Kolon Life Science, Inc., where he continues to advance his research and development efforts. His work at the company reflects his commitment to improving healthcare solutions through innovative technologies.
Collaborations
Some of Jangjoon Park's coworkers include Sujeong Kim and Heonsik Choi. Their collaborative efforts contribute to the success of the projects they undertake together.
Conclusion
Jangjoon Park's contributions to the field of medical science through his patents demonstrate his innovative spirit and dedication to improving patient care. His work continues to inspire advancements in therapeutic methods and pain management.